TNBC-DX genomic test in early-stage triple-negative breast cancer treated with neoadjuvant taxane-based therapy
M. Martín, S.R. Stecklein, Oleg Gluz, Guillermo Villacampa, Marı́a del Monte-Millán, Ulrike Nitz, S. Cobo, M Christgen, F. Brasó-Maristany, Enrique Alarcón Álvarez, Isabel Echavarría, B. Conte, Sherko Küemmel, Coralia Bueno, Yolanda Jerez, R Kates, M. Cebollero, Cornelia Kolberg-Liedtke, Oscar Bueno, José Á. García-Sáenz, F. Moreno, Eva‐Maria Grischke, Helmut Forstbauer, Michael Braun, Mathias Warm, John Hackmann, Christoph Uleer, Bahriye Aktas, Christoph Schumacher, R Wuerstleins, M Graeser, Christine zu Eulenburg, H. Kreipe, Henry Gómez, T. Massarrah, Blanca Herrero, Laia Paré, U. Bohn, S. López-Tarruella, A. Vivancos, Esther Sanfeliu, J.S. Parker, C.M. Perou, Patricia Villagrasa, A. Prat, Pradeep Kumar Sharma, N. Harbeck
Topics & Concepts
MedicineTaxaneTriple-negative breast cancerOncologyStage (stratigraphy)Neoadjuvant therapyBreast cancerInternal medicineTriple negativeChemotherapyCancerPaleontologyBiologyBreast Cancer Treatment StudiesCancer Immunotherapy and BiomarkersCancer Research and Treatments